About Livongo
Livongo by Teladoc Health is a comprehensive digital chronic condition management platform that serves over 730,000 patients with conditions including diabetes, hypertension, and weight challenges. The company provides a one-of-a-kind approach combining connected health-monitoring devices, certified health coaches, and support from physicians and mental health specialists. Members receive smart devices such as blood glucose meters with unlimited strips, blood pressure monitors, and connected scales that automatically upload health data. The platform offers personalized health plans tailored to individual lifestyles, goals, and health data, with support available in multiple languages including Spanish. Livongo's program is based on clinical standards of care from leading organizations including the American Diabetes Association, American Heart Association, and Centers for Disease Control and Prevention. The service includes unlimited access to dedicated health coaches who monitor diet, exercise, medication, motivation, nutrition, and mental health. With 24/7 monitoring capabilities, the team proactively reaches out when dangerous health levels are detected. The platform has demonstrated significant clinical outcomes, including a 48% reduced incidence of diabetes over three years, 15mmHg average systolic blood pressure reduction, and 46% of patients losing 5% or more of their starting weight. Livongo is available at no cost to eligible members through their employer, health plan, or healthcare provider, and includes a mobile app for tracking progress and accessing personalized insights.
Clinical Focus
Medical conditions and clinical areas addressed by Livongo.
Who It Serves
Milestones & Awards
Recent Milestones
Serving 730,000+ patients, GLP-1 medication prescribing capability added to condition management programs
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.